Abstract
Significantly elevated plasma levels of homocysteine, but not cysteine and cysteinylglycine, were found in treated parkinsonian patients compared to controls. Elevated levels of homocysteine may be either caused by an unknown endogenous metabolic disturbance or by antiparkinsonian treatment, because no association to severity or duration of disease was found. Based on the results of this study one may speculate that homocysteine may be an independent risk factor for vascular disease in Parkinson’s disease.
Dates
Type | When |
---|---|
Created | 22 years, 4 months ago (April 15, 2003, 11:42 a.m.) |
Deposited | 4 months, 1 week ago (April 24, 2025, 12:42 a.m.) |
Indexed | 4 weeks, 2 days ago (Aug. 6, 2025, 8:47 a.m.) |
Issued | 27 years, 8 months ago (Jan. 1, 1998) |
Published | 27 years, 8 months ago (Jan. 1, 1998) |
Published Online | 26 years, 9 months ago (Nov. 20, 1998) |
Published Print | 27 years, 8 months ago (Jan. 1, 1998) |
@article{Kuhn_1998, title={Elevated Plasma Levels of Homocysteine inParkinson’s Disease}, volume={40}, ISSN={1421-9913}, url={http://dx.doi.org/10.1159/000007984}, DOI={10.1159/000007984}, number={4}, journal={European Neurology}, publisher={S. Karger AG}, author={Kuhn, W. and Roebroek, R. and Blom, H. and van Oppenraaij, D. and Przuntek, H. and Kretschmer, A. and Büttner, T. and Woitalla, D. and Müller, T.}, year={1998}, pages={225–227} }